Arimidex Related Clinical Trials
Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer [Active, not recruiting]
Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects [Completed]
Liver Safety Under Upfront Arimidex vs Tamoxifen [Completed]
A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer. [Active, not recruiting]
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid [Active, not recruiting]
Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer [Terminated]
MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer [Active, not recruiting]
Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys [Completed]
Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer [Completed]
Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment [Completed]
ATAC - Arimidex, Tamoxifen Alone or in Combination [Completed]
Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer [Completed]
Anastrozole 1 mg Tablets Under Fasting Conditions [Completed]
A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer [Completed]
Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Conditions [Completed]
Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting Conditions [Completed]
Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. [Completed]
Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC [Recruiting]
STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing) [Recruiting]
Anastrozole 1 mg Tablets Under Fed Conditions [Completed]
Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer [Active, not recruiting]
Arimidex Therapy Compliance Electronic Monitoring System [Completed]
The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer [Recruiting]
Treatment of Sexual Dysfunction in Men With Epilepsy With Testosterone and Either Arimidex or Placebo [Completed]
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer [Terminated]
Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer. [Recruiting]
Arthralgia During Anastrozole Therapy for Breast Cancer [Completed]
Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer [Completed]
A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZDO530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer [Recruiting]
Anastrozole in Patients With Pulmonary Arterial Hypertension [Active, not recruiting]
Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer [Completed]
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer [Recruiting]
To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer [Active, not recruiting]
Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI) [Completed]
ATAC - Endometrial Sub-Protocol [Completed]
Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer [Recruiting]
Second Line Breast Cancer Trial [Completed]
Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer [Completed]
ATAC - Pharmacokinetics (PK) Sub-Protocol [Completed]
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer [Terminated]
Faslodex Advanced Breast Cancer Local Chinese Study [Completed]
Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis] [Active, not recruiting]
Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer [Completed]
Entinostat and Anastrozole in Treating Postmenopausal Women With Triple-Negative Breast Cancer That Can Be Removed by Surgery [Terminated]
Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer [Completed]
Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women [Recruiting]
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ [Active, not recruiting]
Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer [Completed]
Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer [Completed]
Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy [Completed]
Pazopanib Hydrochloride and Anastrozole Before Surgery in Treating Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer [Terminated]
Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer [Completed]
ATAC - Quality of Life Sub-Protocol [Completed]
ATAC - Bone Density Sub-Protocol [Completed]
Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients [Completed]
Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480) [Completed]
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women [Completed]
Anastrozole Administration in Elderly Hypogonadal Men [Completed]
Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions [Completed]
Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions [Completed]
Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women [Active, not recruiting]
Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer [Completed]
Arimidex Bone Mass Index and Oral Bisphosphonates [Completed]
Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy [Completed]
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer [Active, not recruiting]
Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence [Recruiting]
Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery [Active, not recruiting]
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer [Terminated]
Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer [Completed]
Bioequivalence Study of Anastrozole 1 mg Tablet [Completed]
Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer [Terminated]
Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome [Active, not recruiting]
Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment [Completed]
Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer [Terminated]
Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction [Completed]
A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer [Not yet recruiting]
Hormone Blockade in Combination With Targeted Agents [Recruiting]
Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole [Recruiting]
Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer [Recruiting]
Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer [Completed]
Secondary Adjuvant Long Term Study With Arimidex [Active, not recruiting]
Partial Double-Blind, Placebo-Controlled Study to Assess the Effect of Anastrozole on the Endometrium in Healthy Volunteers [Completed]
AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL) [Recruiting]
Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence [Completed]
Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer [Completed]
|